Publications by authors named "Yoshimi Nabe"

Claim this Profile
[
[Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis].
Fumihiko Ouchi, Yuho Najima, Kana Kato, Kaori Kondo, Yasutaka Sadaga, Yoshimi Nabe

Rinsho Ketsueki· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adults.
Kaori Kondo, Yuho Najima, Daichi Sadato, Chizuko Hirama, Kana Kato, Yoshimi Nabe

Leuk Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Drug-induced sarcoidosis-like reaction due to dasatinib in the lung of a patient with chronic myeloid leukemia].
Takumi Kimura, Yoshimi Nabe, Hiroki Yoshino, Ryota Urushihara, Noriaki Tsuji

Rinsho Ketsueki· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Re-administration and Extended Dosing of Brentuximab Vedotin Monotherapy for Relapsed Anaplastic Large Cell Lymphoma in a Vulnerable Patient.
Tomoki Minemura, Shohei Kikuchi, Takuma Fujihira, Yoshimi Nabe, Ryusuke Horaguchi

Cureus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Dermatopathic lymphadenopathy in chronic skin graft-versus-host disease].
Kana Kato, Takeshi Kobayashi, Tsunekazu Hishima, Kaori Kondo, Yasutaka Sadaga, Yoshimi Nabe

Rinsho Ketsueki· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful 30-Day Nirmatrelvir/Ritonavir Treatment of a Patient Who Developed Multi-relapsed COVID-19 After Receiving R-CHOP Against Follicular Lymphoma.
Kou Kimoto, Hitoshi Kawasuji, Yoshihiro Yoshida, Hiroshi Yamada, Shunsuke Yazawa, Yoshimi Nabe

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of COVID-19 on Pulmonary Function in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Yoshimi Nabe, Daichi Sadato, Takashi Toya

Transpl Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response using the inhibitor tazemetostat against multiple relapsed follicular lymphoma in the leukemic phase.
Shohei Kikuchi, Yoshimi Nabe, Ryusuke Horaguchi, Tomoki Minemura, Jun Murakami

Int Cancer Conf J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cranial hypertrophic pachymeningitis with myelodysplastic syndrome.
Shohei Kikuchi, Tomohiro Hayashi, Honoka Nitta, Yusuke Kamihara, Akinori Wada, Yoshimi Nabe

Heliyon· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse].
Kazuya Kurihara, Daichi Sadato, Yuho Najima, Chizuko Hirama, Kyoko Haraguchi, Yoshimi Nabe

Rinsho Ketsueki· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation.
Naoki Shingai, Akihito Ota, Kana Kato, Kaori Kondo, Yasutaka Sadaga, Yoshimi Nabe

Transplant Cell Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL.
Shohei Kikuchi, Akinori Wada, Yusuke Kamihara, Imari Yamamoto, Daiki Kirigaya, Yoshimi Nabe

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.
Shohei Kikuchi, Akinori Wada, Yusuke Kamihara, Kosuke Okazaki, Paras Jawaid, Yoshimi Nabe

Cells· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Massive hyperphosphatemia in clinical tumor lysis syndrome during prophylactic rasburicase use: risk factors and treatment options.
Shohei Kikuchi, Makiko Muro, Yusuke Kamihara, Akinori Wada, Jun Murakami, Yoshimi Nabe

Int Cancer Conf J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of activation induced cytidine deaminase in malignant B-cells expressing two distinct M-components as an etiology of biclonal gammopathy.
Shohei Kikuchi, Akinori Wada, Yusuke Kamihara, Yoshimi Nabe, Tomoki Minemura

Medicine (Baltimore)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early complete response of primary bone marrow B-cell lymphoma treated with rituximab-based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement.
Yoshimi Nabe, Shohei Kikuchi, Yusuke Kamihara, Akinori Wada, Jun Murakami

Clin Case Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis